Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients With Attention Deficit Hyperactivity Disorder
- PMID: 37035791
- PMCID: PMC10080256
- DOI: 10.5765/jkacap.220040
Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients With Attention Deficit Hyperactivity Disorder
Abstract
Objectives: This study investigated the relationship between suicidal behavior and the use of methylphenidate (MPH) or atomoxetine (ATX) in patients with attention deficit hyperactivity disorder (ADHD).
Methods: The Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines were used to conduct a meta-analysis. The Physiotherapy Evidence Database scale was used to score the quality of the studies.
Results: Nine studies were included in this quantitative analysis. The analysis included 602864 patients with ADHD (521125 and 81739 patients were taking methylphenidate [MPH group] and atomoxetine [ATX group], respectively) and 19230 healthy controls. The overall estimates were in the order of the control, MPH, and ATX groups; however, no statistically significant between-group difference was observed in the incidence of events (p=0.553 for control vs. MPH; p=1.000 for control vs. ATX; p=1.000 for MPH vs. ATX).
Conclusion: The rate of suicidal behavior was higher in the ADHD groups treated with MPH and ATX than in the control group. However, no statistically significant difference was observed between the ADHD groups treated with MPH and ATX, and the control group. Therefore, MPH and ATX did not increase suicidal behavior.
Keywords: Atomoxetine; Attention deficit hyperactivity disorder; Methylphenidate; Suicide.
Copyright © 2023 Korean Academy of Child and Adolescent Psychiatry.
Conflict of interest statement
Conflicts of Interest The authors have no potential conflicts of interest to disclose.
Figures
References
-
- American Psychiatric Association, author. Diagnostic and statistical manual of mental disorders. 5th ed. American Psychiatric Association; Arlington, VA: 2013. - DOI
-
- Visser SN, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD, Ghandour RM, et al. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry. 2014;53:34–46.e2. doi: 10.1016/j.jaac.2013.09.001. - DOI - PMC - PubMed
-
- National Institute of Mental Health, author. Trends in prevalence of ADHD diagnosis among children [Internet] NIMH; Bethesda, MD: [cited 2022 Aug 18]. Available from: https://www.nimh.nih.gov/health/statistics/attention-deficit-hyperactivi... .
Publication types
LinkOut - more resources
Full Text Sources